rss
Br J Ophthalmol 86:31-34 doi:10.1136/bjo.86.1.31
  • Scientific correspondence

Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias

Table 2

Patient data

No Age/sex Diagnosis Indication Treatment TG FU Post-treatment result Complications
PAM, primary acquired melanosis; PED, persistent epithelial defect; g MMC mitomycin C 0.04% eye drops; CA, carcinoma; TG, treatment group; FU, follow up in months.
1 61/F Conj melanoma + PAM + atypia 18 May 98 A 23 Adequate clearance Nil
Excision + MMC Extending just to margins
0.4 mg/ml × 3 mins No recurrence
2 61/F RE Conj melanoma × 6/12 Recurrence 26 Nov 98 A 17 Regression despite margins Nil
Margins not clear Excision + MMC NOT clear
0.4 mg/ml × 4 mins
3 72/M RE Bulbar conj Margins not clear. 05 Aug 99 A 8 Clear margins on specimens Nil
Bowenoid dysplasia Risk of recurrence Excision + MMC No recurrence
0.4 mg/mi × 3 mins + conj autograft
4 41/F PAM with mild atypia Increasing in size 23 Mar 00 A 1 Good response Nil
Excision + MMC
0.4 mg/ml × 3.5 min
5 71/F Conj CA in situ Recurrence + 2° cicatricial change g MMC B Aborted after 4 days + PED
6 89/F LE Conj melanoma Margins not clear Mar 96 proton beam therapy B Good response
Extensive lesions
Post-proton residual pig Jun 99 Poorly tolerated
g MMC
7 57/M LE Conj PAM + atypia Extensive lesions Dec 98 + B 16 Regression Nil
Jun 99
g MMC Cryo to residual pigment
8 73/F RE Conj PAM + atypia Recurrence of melanoma + margins not clear Jul 99 B 9 Regression Nil
g MMC
9 64/F Conj squamous CA Canalicular involvement 06 Jan 00 g MMC C 3 Reduction in size Reaction in the second phase but continued with topical steroid cover
06 Apr 00 1 Good response
Excision + MMC Retaining VA 6/6
0.4 mg/ml × 3.5 mins
10 65/F Sebaceous gland CA Extensive lesions + caruncle involved 21 Jan 00 C 4 Some reduction in size Nil
g MMC
27 Apr 00
Excision
11 80/F Sebaceous gland CA Intra-epithelial spread 02 Jul 98 D 18 PED
Excision + MMC
0.4 mg/ml × 3 mins +
g MMC × 2/52
06 Jan 00 4 Biopsy PED
Recurrence g MMC × 3/52 −ve on 13.06.00

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.